Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile: Waters Corporation (WAT)

WAT insider trades (13 months) →

$459.90 +2.31% vs. previous close · Market cap $45.16B

Today's multi-factor rank: 197 of 461 · see the ranking

Quant500 Scores
Momentum
5.7/10
Value
4.2/10
Growth
4.9/10
Quality
5.3/10
Multifactor
5.0/10

Market and Valuation

Price & Market

Prev Close Price:$449.53
Open:$456.61
Day's Low:$449.51
Day's High:$474.29
Bid / Ask:-
Market Cap:45.16B
Enterprise Value:49.10B

52-Week Range

52-Week Low:$282.77
52-Week High:$482.28
Current position in 52-week range
52w Low-52w High
50-Day Avg:$430.96
200-Day Avg:$369.79

Volume

Volume Today:1,793,365
Avg Volume (3m):825,645
Avg Volume (10d):1,065,160
52-Week Change:+22.37%
vs S&P 500, 52 weeks:-
Beta:1.15

Valuation Multiples

P/E (trailing):114.69

Diluted EPS for the last 12 months: the four quarters ended Jul 4, 2026, from the accounts filed with the SEC on Aug 11, 2026. The P/E is the price divided by that EPS.

P/E (forward):27.79
PEG Ratio:1.67
Price / Book:2.97
Price / Sales (TTM):9.72
EV / Revenue:10.57
EV / EBITDA:33.82

Dividends

Current yield:-
Annual Dividend Rate:-
Dividend Trailing:$0.00
Yield Trailing:0.00%
5-Year Avg Yield:-
Payout Ratio:0.00%
Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-
Fiscal Year (Next):-

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):4.64B
Gross Profit:2.62B
EBITDA:1.45B
Net Income (TTM):166.63M
Rev Growth (YoY):+113.40%
Earnings Growth (YoY):-
Quarterly earnings growth (YoY):-

Margins

Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-

Per Share

EPS Trailing (TTM):$4.01

Diluted EPS for the last 12 months: the four quarters ended Jul 4, 2026, from the accounts filed with the SEC on Aug 11, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$16.55
Revenue Per Share:$62.10
Cash Per Share:-
Book Value:$154.70
Last Dividend:-
Ex-Dividend Date:-
Last Split:-

Balance Sheet & Liquidity

Total cash:539.00M
Total Debt:5.48B
Net Debt (Debt - Cash):4.94B
Debt / Equity:36.05%
Current Ratio:1.86
Quick Ratio:1.05

Cash Flows

Operating Cash Flow:549.56M
Free Cash Flow (FCF):−142.07M
FCF Yield (FCF / Market Cap):-
Enterprise Value:49.10B
EV / Revenue:10.57
EV / EBITDA:33.82

Profitability

ROE (Return on Equity):1.92%
ROA (Return on Assets):3.56%
P/E (trailing):114.69
P/E (forward):27.79
Price / Book:2.97
PEG Ratio:1.67
52-Week Change:+22.37%
S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$4.01

Diluted EPS for the last 12 months: the four quarters ended Jul 4, 2026, from the accounts filed with the SEC on Aug 11, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$16.55
P/E (forward):27.79
PEG Ratio:1.67

Growth and Margins

Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-

Per Share

Revenue Per Share:$62.10
Cash Per Share:-
Book Value:$154.70

Cash Flows (TTM)

Free Cash Flow:−142.07M
Operating Cash Flow:549.56M
EBITDA:1.45B
Total Revenue (TTM):4.64B
Net Income (TTM):166.63M
Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter Period Actual EPS Estimated EPS Difference Surprise % Currency

Ownership Structure

Ownership Distribution

% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:98,185,855
Float (free shares):98,065,370
Short interest (shares):3,191,944
Short % of float:-
Short Ratio (days to cover):3.72
Short interest, prior month:-
Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization Report Date % Shares No. Shares Value (USD) Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund Report Date % Shares No. Shares Value (USD) Change %

Recent Insider Trades

Executive / Insider Title Date Action Shares

Options Chain

CALLS

StrikeLastBidAskVol.O.I.IV

PUTS

StrikeLastBidAskVol.O.I.IV

Waters Corporation (WAT) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type Date Official link
8-K2026-11-03View filing ↗
8-K2026-08-21View filing ↗
10-Q2026-08-11View filing ↗
8-K2026-08-04View filing ↗
11-K2026-06-25View filing ↗
SD2026-05-29View filing ↗
8-K2026-05-22View filing ↗
10-Q2026-05-12View filing ↗
8-K2026-05-05View filing ↗
DEFA14A2026-04-09View filing ↗

Company and Executive Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

General Information

Headquarters:United States
City:Milford
Employees:16,000
Sector:Healthcare
Industry:Diagnostics & Research
Website:-

Key Executives

NameTitleAgeTotal pay
Dr. Udit Batra Ph.D.President, CEO & Director543.54M
Mr. Amol ChaubalSenior VP & CFO491.42M
Ms. Jianqing Y. BennettSenior Vice President of Waters Advanced Diagnostics Division551.18M
Mr. Mark GladwellSVP of Global Operations50-
Mr. Brook M. ColangeloSenior VP & Chief Information Officer47-
Mr. Caspar TudorHead of Investor Relations--
Ms. Keeley A. Aleman J.D.Senior VP, General Counsel, Head of Global Human Resources & Corporate Secretary48897,333
Ms. Kristen GarveySenior Vice President of Global Communications--

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

Waters Corporation (WAT): Quantitative Analysis

Waters Corporation (WAT) — Healthcare — Diagnostics & Research. WAT is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, WAT has returned +21.1% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.

WAT ranks 197 of 461 on today's multifactor score, and 26 of the 55 Healthcare companies that score. Its strongest factor is momentum (Z 0.42, ranked 141 of 494); its weakest is value (Z -0.51, ranked 381 of 489). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

FactorZ-ScoreRank
Multifactor0.005197 of 461
Momentum0.422141 of 494 ↑5
Value-0.510381 of 489
Quality0.178148 of 468 ↓3
Growth-0.071201 of 489

Market data

MetricValue
Price$459.90
Market Cap45.16B
P/E114.69
Revenue (last 12 months)4.64B
Price / book2.97
Book value per share$154.70
52-week range$282.77 – $482.28
Dividend yield0.00%
Beta1.15
Average volume825,645
Shares outstanding98.19M
Short interest (% of float)3.25% (as of Oct 15, 2026)

When does WAT report earnings? 12 of its last 12, before the open →

What are WAT insiders doing? 52 transactions filed with the SEC, of them 2 buys and 1 sell, the last one on Sep 30, 2026 →

WAT latest SEC filings

Filing dates on EDGAR, the SEC's public registry. All WAT filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Waters (WAT)

When does Waters report earnings?

Waters has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 12 before the open (SEC filings through Nov 3, 2026). WAT earnings dates and times, quarter by quarter →

What is Waters's P/E ratio?

Waters's P/E (price over earnings per share for the last twelve months) is 114.7 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jul 4, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Waters is above its sector median. Healthcare stocks, company by company →

Where does Waters rank on Quant500?

In the Nov 3, 2026 multi-factor ranking, Waters ranks 197 of 461, and 26 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking → How it is calculated →

Have Waters insiders bought or sold shares?

The latest open-market purchase of Waters shares filed with the SEC (Form 4) was on Mar 16, 2026, by a director, for $145k. The latest sale was on Aug 6, 2026, by a director, for $1.4M. In total, from August 2025 through Nov 3, 2026: 2 purchases and 1 sale by directors, officers and large shareholders. All WAT insider trades →

What sector is Waters in, and which index?

Waters is classified in the Healthcare sector (industry: Diagnostics & Research), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity